Regeneron

Regeneron is a leading biotechnology company that specializes in the discovery, development, and commercialization of innovative medicines for serious diseases.
Regeneron's mission is to use the power of science to bring new and effective treatments to patients in need. Through its rigorous research and development efforts, the company aims to address unmet medical needs and improve patient outcomes. With a portfolio of diverse therapeutic areas, including oncology, ophthalmology, and infectious diseases, Regeneron strives to deliver innovative solutions that have the potential to revolutionize healthcare.
Collaboration lies at the heart of Regeneron's corporate culture. The company actively seeks partnerships with academic institutions, other biotech companies, and pharmaceutical organizations to accelerate the discovery and development of new therapies. By harnessing the collective expertise and resources of its partners, Regeneron aims to expedite the translation of scientific discoveries into life-saving treatments.
At Regeneron, the patient is at the center of everything they do. The company is driven by a deep sense of responsibility to improve the lives of individuals affected by serious diseases.